» Articles » PMID: 19586544

Coordinated Patterns of Gene Expressions for Adult Muscle Build-up in Transgenic Mice Expressing Myostatin Propeptide

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2009 Jul 10
PMID 19586544
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Skeletal muscle growth and maintenance are essential for human health. One of the muscle regulatory genes, namely myostatin, a member of transforming growth factor-beta, plays a dominant role in the genetic control of muscle mass. Myostatin is synthesized as a precursor protein, which generates the N-terminal propeptide and the C-terminal mature myostatin peptide by a post-translational cleavage event. Previously, transgenic over-expression of myostatin propeptide in skeletal muscle results in significant muscle growth in early stages of development. The objectives of present study were to further characterize muscle growth in later stages of life and to identify genes and their expression patterns that are responsible for adult muscle build-up by myostatin propeptide.

Results: Immunohistochemical staining with an antibody to the N-terminus indicates a high level of myostatin propeptide present in the muscles of transgenic mice while there were no apparent differences in myostatin protein distribution in the muscle fibers between the transgenic and wild-type mice. Main individual muscles increased by 76-152% in the transgenic mice over their wild-type littermate mice at 12 months of age. A large number of nuclei were localized in the central and basal lamina of the myofibers in the transgenic mice as the number of nuclei per fiber and 100 microm(2) area was significantly higher in transgenic mice than wild-type mice. By systemic comparisons of global mRNA expression patterns between transgenic mice and wild-type littermates using microarray and qRT-PCR techniques, we have identified distinct gene expression patterns to support adult muscle build-up by myostatin propeptide, which are comprised of enhanced expressions of myogenic regulatory factors and extracelullar matrix components, and differentially down-regulated expressions of genes related to protein degradation and mitochondrial ATP synthesis.

Conclusion: The results present a coordinated pattern of gene expressions for reduced energy utilization during muscle build-up in adult stage. Enhanced muscle buildup by myostatin propeptide is sustained by reduced ATP synthesis as a result of a decreased activity of protein degradation. Myostatin propeptide may have a therapeutic application to the treatment of clinical muscle wasting problems by depressing myostatin activity.

Citing Articles

Loss of Myostatin Alters Mitochondrial Oxidative Phosphorylation, TCA Cycle Activity, and ATP Production in Skeletal Muscle.

Wang X, Wei Z, Gu M, Zhu L, Hai C, Di A Int J Mol Sci. 2022; 23(24).

PMID: 36555347 PMC: 9779574. DOI: 10.3390/ijms232415707.


Muscle Hyperplasia in Japanese Quail by Single Amino Acid Deletion in MSTN Propeptide.

Lee J, Kim D, Lee K Int J Mol Sci. 2020; 21(4).

PMID: 32098368 PMC: 7073117. DOI: 10.3390/ijms21041504.


Rapamycin suppresses postnatal muscle hypertrophy induced by myostatin-inhibition accompanied by transcriptional suppression of the Akt/mTOR pathway.

Choi D, Yang J, Kim Y Biochem Biophys Rep. 2019; 17:182-190.

PMID: 30805561 PMC: 6362869. DOI: 10.1016/j.bbrep.2018.12.009.


Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.

Jeong Y, Daghlas S, Kahveci A, Salamango D, Gentry B, Brown M Muscle Nerve. 2017; 57(2):294-304.

PMID: 28555931 PMC: 5702601. DOI: 10.1002/mus.25706.


RNA sequencing identifies upregulated kyphoscoliosis peptidase and phosphatidic acid signaling pathways in muscle hypertrophy generated by transgenic expression of myostatin propeptide.

Miao Y, Yang J, Xu Z, Jing L, Zhao S, Li X Int J Mol Sci. 2015; 16(4):7976-94.

PMID: 25860951 PMC: 4425062. DOI: 10.3390/ijms16047976.


References
1.
Reardon K, Davis J, Kapsa R, Choong P, Byrne E . Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve. 2001; 24(7):893-9. DOI: 10.1002/mus.1086. View

2.
CHASSON A, GRADY H, Stanley M . Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol. 1960; 30:207-12. View

3.
Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G . Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res. 2003; 286(2):263-75. DOI: 10.1016/s0014-4827(03)00074-0. View

4.
Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier J, Verdiere-Sahuque M . Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol. 1999; 205(1):158-70. DOI: 10.1006/dbio.1998.9107. View

5.
Amthor H, Nicholas G, McKinnell I, Kemp C, Sharma M, Kambadur R . Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol. 2004; 270(1):19-30. DOI: 10.1016/j.ydbio.2004.01.046. View